We are live on ! Find out more
KXA

KPCB XII Associates Portfolio holdings

AUM $738K
1-Year Est. Return 3.15%
This Fund
S&P 500
This Quarter Est. Return
+13.43%
1 Year Est. Return
-3.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$41.7M
AUM Growth
-$20.6M
Cap. Flow
-$27.8M
Cap. Flow %
-66.74%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CBLK
Carbon Black, Inc. Common Stock
CBLK
+$27.8M

Sector Composition

Rank Sector Weight
1 Healthcare 57.65%
2 Technology 40.19%
3 Materials 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSP icon
1
Inspire Medical Systems
INSP
$1.46B
$24M 57.65%
396,406
CBLK
2
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$16.8M 40.19%
1,002,253
-1,813,200
-64% -$27.8M
AMRS
3
DELISTED
Amyris Inc.
AMRS
$900K 2.16%
252,834

Similar funds

KPCB XII Associates's Q2 2019 Portfolio in Review

As of Q2 2019, KPCB XII Associates held 3 positions worth $41.7M, down 33% from $62.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

KPCB XII Associates withdrew a net $27.8M in Q2 2019, reducing 1 holding. Its largest reduction was Carbon Black, Inc. Common Stock, cutting an estimated $27.8M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 36% a quarter earlier, followed by Technology and Materials.

  • KPCB XII Associates's biggest Q2 2019 reduction was Carbon Black, Inc. Common Stock, cutting an estimated $27.8M.
  • KPCB XII Associates's ten largest holdings make up 100% of its $41.7M portfolio in Q2 2019.
  • KPCB XII Associates opened 0 new positions and closed 0 in Q2 2019.
  • KPCB XII Associates's portfolio value fell 33% quarter-over-quarter to $41.7M.

Based on KPCB XII Associates's 13F filing for Q2 2019, filed 7 Aug 2019.